SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/ABBF0E9A46D89619A0B9578A171DC5A83DE8E972C8C8100AC2F058221184708F7A51D47BF62A3304901E9C47B7F66A09>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/ABBF0E9A46D89619A0B9578A171DC5A83DE8E972C8C8100AC2F058221184708F7A51D47BF62A3304901E9C47B7F66A09
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/ABBF0E9A46D89619A0B9578A171DC5A83DE8E972C8C8100AC2F058221184708F7A51D47BF62A3304901E9C47B7F66A09
http://www.w3.org/2000/01/rdf-schema#comment
"Our studies have identified three specific alleles HLA-A*33:01 HLA-B*44:03 and HLA-DRB1*07:01 to be significantly increased in vitiligo patients as compared with controls in both the initial study on North Indians."
xsd:string
http://purl.uniprot.org/uniprot/#_AC79BD693E3A456CE4EE276A8B4500D7E09BF2D240B7B1B7E9022B50B7711269C9896492115D3C35CC80E9B789622015
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/ABBF0E9A46D89619A0B9578A171DC5A83DE8E972C8C8100AC2F058221184708F7A51D47BF62A3304901E9C47B7F66A09
http://purl.uniprot.org/uniprot/K7RE34
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/ABBF0E9A46D89619A0B9578A171DC5A83DE8E972C8C8100AC2F058221184708F7A51D47BF62A3304901E9C47B7F66A09
http://purl.uniprot.org/uniprot/#_K7RE34-mappedCitation-21833019
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/ABBF0E9A46D89619A0B9578A171DC5A83DE8E972C8C8100AC2F058221184708F7A51D47BF62A3304901E9C47B7F66A09